X-Received: by 2002:a05:600c:3d99:b0:39c:55ba:ecc3 with SMTP id bi25-20020a05600c3d9900b0039c55baecc3mr27584851wmb.42.1655573881039;
Sat, 18 Jun 2022 10:38:01 -0700 (PDT)
X-Received: by 2002:ad4:584c:0:b0:464:5904:998d with SMTP id
de12-20020ad4584c000000b004645904998dmr13033662qvb.33.1655573880417; Sat, 18
Jun 2022 10:38:00 -0700 (PDT)
Path: i2pn2.org!i2pn.org!aioe.org!news.mixmin.net!proxad.net!feeder1-2.proxad.net!209.85.128.88.MISMATCH!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: comp.sys.cbm
Date: Sat, 18 Jun 2022 10:38:00 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=217.138.255.202; posting-account=sOWXZQoAAAAGTOO5XFyr-r49rd7H6xeC
NNTP-Posting-Host: 217.138.255.202
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <9ec55615-61a6-494f-add8-25f65fd242a0n@googlegroups.com>
Subject: (PDF) Viral Vectors for Gene Therapy by Fredric P. Manfredsson
From: hesterholt9@gmail.com (hester holt)
Injection-Date: Sat, 18 Jun 2022 17:38:01 +0000
Content-Type: text/plain; charset="UTF-8"